68.81
Precedente Chiudi:
$68.96
Aprire:
$68.72
Volume 24 ore:
524.00K
Relative Volume:
0.79
Capitalizzazione di mercato:
$2.90B
Reddito:
$17.39M
Utile/perdita netta:
$-135.89M
Rapporto P/E:
-14.83
EPS:
-4.64
Flusso di cassa netto:
$-123.00M
1 W Prestazione:
+4.16%
1M Prestazione:
+15.78%
6M Prestazione:
+32.56%
1 anno Prestazione:
+54.66%
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
Nome
Tarsus Pharmaceuticals Inc
Settore
Industria
Telefono
(949) 409-9820
Indirizzo
15440 LAGUNA CANYON ROAD, IRVINE
Confronta TARS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TARS
Tarsus Pharmaceuticals Inc
|
68.81 | 2.91B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-05-27 | Ripresa | H.C. Wainwright | Buy |
| 2023-11-20 | Iniziato | Goldman | Neutral |
| 2023-07-18 | Iniziato | William Blair | Outperform |
| 2023-05-18 | Iniziato | Guggenheim | Buy |
| 2022-08-01 | Iniziato | Barclays | Overweight |
| 2021-12-21 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-23 | Iniziato | Oppenheimer | Outperform |
| 2020-11-10 | Iniziato | BofA Securities | Buy |
| 2020-11-10 | Iniziato | Jefferies | Buy |
| 2020-11-10 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-11-10 | Iniziato | Raymond James | Strong Buy |
Mostra tutto
Tarsus Pharmaceuticals Inc Borsa (TARS) Ultime notizie
How analysts rate Tarsus Pharmaceuticals Inc. stock todayJuly 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Tarsus Pharmaceuticals Inc. stock cheap at current valuation2025 Geopolitical Influence & Consistent Growth Equity Picks - newser.com
Can Tarsus Pharmaceuticals Inc. recover in the next quarter2025 Market Sentiment & Daily Market Momentum Tracking - newser.com
Top chart patterns to watch in Tarsus Pharmaceuticals Inc.2025 Big Picture & Precise Entry and Exit Recommendations - newser.com
Forecasting Tarsus Pharmaceuticals Inc. price range with options dataEarnings Summary Report & Free Safe Capital Growth Stock Tips - newser.com
What’s the recovery path for long term holders of Tarsus Pharmaceuticals Inc.Market Risk Analysis & Growth Oriented Trade Recommendations - newser.com
Is Tarsus Pharmaceuticals Inc. showing signs of accumulation2025 Winners & Losers & Precise Trade Entry Recommendations - newser.com
Can Tarsus Pharmaceuticals Inc. stock resist market sell offs2025 Investor Takeaways & Weekly High Return Stock Opportunities - newser.com
Is Tarsus Pharmaceuticals Inc. stock a safe investment in uncertain marketsLong Setup & Real-Time Stock Entry Alerts - newser.com
Tarsus Pharmaceuticals Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Tarsus Pharmaceuticals (TARS) to Release Earnings on Tuesday - MarketBeat
What to expect from Tarsus Pharmaceuticals Inc. in the next 30 days2025 Top Gainers & Step-by-Step Trade Execution Guides - newser.com
Jennison Associates LLC Trims Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Applying sector rotation models to Tarsus Pharmaceuticals Inc.2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com
Will Tarsus Pharmaceuticals Inc. stock deliver shareholder value2025 Market Overview & Weekly High Return Opportunities - newser.com
Is Tarsus Pharmaceuticals Inc. stock poised for growth2025 Market Outlook & Daily Stock Trend Watchlist - newser.com
Tarsus Pharmaceuticals Inc. stock trend outlook and recovery pathGold Moves & Risk Controlled Stock Alerts - newser.com
Full technical analysis of Tarsus Pharmaceuticals Inc. stockWeekly Investment Report & Verified Momentum Watchlists - newser.com
Allianz Asset Management GmbH Purchases New Holdings in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Pharmaceuticals, Inc. to Host Live Webcast for Q3 2025 Financial Results and Corporate Update - Quiver Quantitative
Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - GlobeNewswire
Can Tarsus Pharmaceuticals Inc. stock sustain market leadershipPortfolio Growth Summary & Risk Managed Investment Signals - newser.com
Tarsus Pharmaceuticals Inc Azioni (TARS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):